Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New contraceptive options.

D F Archer1

  • 1Department of Obstetrics and Gynecology, Jones Institute of Reproductive Medicine, 601 Colley Avenue, Norfolk, VA 23507, USA.

Clinical Obstetrics and Gynecology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uterine bleeding with hormone therapies in menopausal women: a systematic review.

Climacteric : the journal of the International Menopause Society·2020
Same author

A pilot study: estradiol/progesterone effect on cervico-vaginal cytokines in premenopause and postmenopause.

Climacteric : the journal of the International Menopause Society·2020
Same author

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2019
Same author

Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.

Contraception·2018
Same author

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Climacteric : the journal of the International Menopause Society·2017
Same author

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.

Climacteric : the journal of the International Menopause Society·2015

New contraceptive options offer diverse delivery methods, including pills, patches, and implants. Research also advances barrier methods for preventing sexually transmitted infections like HIV and bacterial infections.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Infectious Disease Prevention

Background:

  • Steroidal contraceptives are evolving with new delivery systems beyond oral pills.
  • These include transdermal patches, intravaginal rings, intrauterine devices, implants, and injectables.
  • Consumer choice is enhanced by diverse administration routes for steroidal products.

Purpose of the Study:

  • To review emerging contraceptive modalities in the US market.
  • To highlight advancements in barrier contraceptives with potential for infection prevention.
  • To compare the profiles and potential benefits of different contraceptive types.

Main Methods:

  • Literature review of current contraceptive product landscape.
  • Analysis of new delivery systems for steroidal contraceptives.

Related Experiment Videos

  • Overview of clinical trial progress for novel barrier contraceptives.

    • Main Results:

    • Steroidal contraceptives are now available in multiple delivery formats (oral, transdermal, intravaginal, intrauterine, injectable, implantable).
    • New barrier contraceptives are in clinical development, aiming to reduce human immunodeficiency virus (HIV) and bacterial infection transmission.
    • Barrier methods may exhibit lower efficacy than steroidal options but offer significant public health benefits.

    Conclusions:

    • Diverse contraceptive options empower consumers with personalized choices.
    • Emerging barrier contraceptives hold promise for preventing sexually transmitted infections.
    • While steroidal products offer high efficacy, barrier methods provide crucial additional health benefits.